Intra-Cellular Therapies, Inc.ITCI

Market cap

$13.4B

P/E ratio

	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	35	61	47	49	38	55	108	61	94	150	150	309
Marketable securities, current	-	-	428	335	427	293	116	1,195	320	443	350	694
Total cash & short-term investments	35	61	475	384	464	348	224	1,256	414	594	500	1,003
Accounts receivable, net	336,318	51,603	30,660	94,339	-	-	-	11	20	75	114	167
Inventories	-	-	-	-	-	-	-	7	8	24	12	26
Total current assets	38	131	483	388	469	355	230	691	467	738	668	1,307
Property, plant and equipment, net	68,272	54,553	775,522	627,614	1	1	2	2	2	2	2	1
Total non-current assets	199,827	125,497	847,397	703,379	2	2	21	26	23	17	60	60
Total assets	38	131	484	389	471	357	251	717	490	755	728	1,367
Accounts payable	3	2	2	4	6	14	7	6	9	10	11	26
Total current liabilities	7	11	6	11	14	36	36	37	53	83	124	206
Total non-current liabilities	-	-	2	3	3	3	20	24	19	15	13	13
Total liabilities	-	-	8	13	17	39	56	60	72	99	137	218
Common stock and paid-in capital	89	209	4,316	4,329	5,460	5,490	5,551	8,046	8,000	0	0	0
Retained earnings	-57,564,497	-88,255,957	-193,049,098	-309,475,366	-407,248,780	-562,376,191	-710,098,369	-937,104,032	-1,221,229,698	-1,477	-1,617	-1,692
Stockholders' equity	32	121	476	376	454	318	195	657	418	656	591	1,148
Working capital	-	-	-	-	-	-	-